Adar Poonawalla
CEO @ Serum Institute of India Pvt. Ltd.
Pune, India
Adar Poonawalla is a seed investor at Serum Institute of India Pvt. Ltd. in Pune focused on Software and Health Care. Adar C. Poonawalla is based out of Pune, Maharashtra, and is the Board of Directors of Rajasthan Royals and CEO of Serum Institute of India Pvt. Ltd. Adar C. Poonawalla attended the University of Westminster.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 70%
Last updated:
For AI agents: llms.txt
Industries Adar Poonawalla invests in
Stages Adar Poonawalla invests in
Countries Adar Poonawalla invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1M–$3M
Investment Focus
Industry
- Software 2 (20%)
- Health Care 2 (20%)
- Biotechnology 2 (20%)
- Retail 1 (10%)
- Medical 1 (10%)
Stage
- Seed 3 (30%)
- Venture - Series Unknown 3 (30%)
- Post-IPO Equity 1 (10%)
Country
- India 6 (60%)
- United Kingdom 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ImmunifyMe Healthcare Technologies Pvt Ltd
|
ImmunifyMe leverage BlockChain to monitor the immunization and maintain records of each and every child for their vaccination. It’s an ecosystem supported with a Mobile App and a smart Card. Our technology ensures no child goes unimmunized. | $3M / Seed / Nov 19, 2021 | |
Oxford BioMedica
|
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research, development and manufacture. Gene therapy is the treatment of disease by delivering therapeutic DNA into a patient’s cells. This can be either in vivo or ex vivo, the latter encompassing the field of cell therapywhereby genetically modified cells are put back into the body. Their pipeline of seven gene and cell therapy therapy products addresses diseases for which there is currently no treatment or that are inadequately treated today, including ocular and central nervous system disorders. Their product candidates have the potential to transform treatment landscapes. Their strategy is to develop their product candidates to their next value inflection points whilst continuing to build OXB Solutions into a valuable revenue-generating manufacturing and development services business. | $68.1M / Post-IPO Equity / Sep 22, 2021 | |
JetSynthesys
|
JetSynthesys Pvt. Ltd. is part of the Navani family owned JetLine Group of Companies. JetSynthesys is the group's most innovative company in the promising Digital and Technology Business World with a vision to create world class digital products, platforms and services in India and play an active role in the digital daily life of 1.2 billionIndians extending that to all individuals on the planet through very powerful targeted big data analytics and unbeatable content and user experiences. | Venture - Series Unknown / Jul 29, 2021 | |
Svasti Microfinance
|
Operating in the urban slums of Mumbai, Svasti is a startup NBFC-MFI innovatively using technology and focusing on product design. Its microfinance program was started in October 2008. The Indian microfinance market is still largely under-penetrated, and the market is very fragmented with over 1500+ MFIs, but only a handful have an NBFC formallowing to receive equity investments like Svatsi. | $4.3M / Venture - Series Unknown / Mar 11, 2021 | |
Wellness Forever Medicare
|
Mumbai-based retail pharmacy chain Wellness Forever Medicare Pvt Ltd.Wellness Forever currently has a chain of 70 lifestyle pharmacies and wellness stores oThe firm operates under three formats- retail pharmacies, hospital pharmacies and managed franchises.perating on 24x7 basis in Mumbai, Pune, Nashik, Belgaum and rest of Maharashtra. | $17.6M / Venture - Series Unknown / Nov 09, 2020 | |
|
JetSynthesys
|
JetSynthesys Pvt. Ltd. is part of the Navani family owned JetLine Group of Companies. JetSynthesys is the group's most innovative company in the promising Digital and Technology Business World with a vision to create world class digital products, platforms and services in India and play an active role in the digital daily life of 1.2 billionIndians extending that to all individuals on the planet through very powerful targeted big data analytics and unbeatable content and user experiences. | $40M / Venture - Series Unknown / Jul 08, 2020 | |
Mylab Discovery Solutions
|
Mylab Discovery Solutions is a Young and Dynamic Biotechnology company, that develops and commercializes molecular diagnostic detection kits, to empower labs to obtain reliable, timely, and actionable answers. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedicalresearch, agrigenomics and animal and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. | Seed / Apr 02, 2020 | |
Sweetish House Mafia
|
Sweetish House Mafia is a cookie chain. | $1.7M / Seed / Feb 26, 2020 | |
|
Svasti Microfinance
|
Operating in the urban slums of Mumbai, Svasti is a startup NBFC-MFI innovatively using technology and focusing on product design. Its microfinance program was started in October 2008. The Indian microfinance market is still largely under-penetrated, and the market is very fragmented with over 1500+ MFIs, but only a handful have an NBFC formallowing to receive equity investments like Svatsi. | $10M / Venture - Series Unknown / Nov 10, 2019 | |
|
ImmunifyMe Healthcare Technologies Pvt Ltd
|
ImmunifyMe leverage BlockChain to monitor the immunization and maintain records of each and every child for their vaccination. It’s an ecosystem supported with a Mobile App and a smart Card. Our technology ensures no child goes unimmunized. | $1M / Seed / Sep 01, 2019 |
Co-Investors
About Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. is the vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at leastone vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 140 countries across the globe in their national immunization programs, saving millions of lives throughout the world.
Serum Institute of India Pvt. Ltd. Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Adar Poonawalla
CEO
|
|||
Natasha Poonawalla
Director
|
|||
Cyrus S. Poonawalla
Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Adar Poonawalla invest in?
Adar Poonawalla invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 10 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Adar Poonawalla's check size?
Adar Poonawalla typically joins rounds of $1M–$3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Adar Poonawalla participates in.
How do I contact Adar Poonawalla?
Public channels for Adar Poonawalla include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Adar Poonawalla last invest?
The most recent investment recorded for Adar Poonawalla closed in Nov 2021. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
